Quarterly report pursuant to Section 13 or 15(d)

Balance Sheet

v3.19.1
Balance Sheet - USD ($)
Mar. 31, 2019
Dec. 31, 2018
Current assets:    
Cash and cash equivalents $ 5,881,064 $ 6,892,772
Deferred offering costs 371,113 344,936
Other current assets 101,627 80,247
Total current assets 6,353,804 7,317,955
Total assets 6,353,804 7,317,955
Current liabilities:    
Accounts payable, accrued expenses and other current liabilities 579,986 399,551
Total current liabilities 579,986 399,551
Total liabilities 579,986 399,551
Commitments and contingencies (Note 7)
Stockholders' equity:    
Common stock, par value of $0.001 per share, 40,000,000 shares authorized, 9,291,421 shares issued and outstanding at March 31, 2019 and December 31, 2018 9,291 9,291
Additional paid-in capital 28,800,997 28,567,221
Accumulated deficit (23,031,947) (21,655,412)
Accumulated other comprehensive loss (4,523) (2,396)
Total stockholders' equity 5,773,818 6,918,404
Total liabilities and stockholders' equity $ 6,353,804 $ 7,317,955